(Prototype team page) |
|||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
− | + | <html lang="en"> | |
− | + | ||
− | <html> | + | |
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <meta http-equiv="X-UA-Compatible" content="IE=edge"> | ||
+ | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
+ | <title>Shanghai_Metro_Utd</title> | ||
+ | <link rel="stylesheet" | ||
+ | href="https://2021.igem.org/wiki/index.php?title=Template:Shanghai_Metro_Utd/Main_CSS&action=raw&ctype=text/css" /> | ||
− | + | </head> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
+ | <body> | ||
+ | <nav class="head-nav clearfix"> | ||
+ | <div class="top-block"></div> | ||
+ | <div class="top-nav-bar"> | ||
+ | <ul class="clearfix"> | ||
+ | <span class="small-logo"></span> | ||
+ | <li> | ||
+ | <a href="https://2021.igem.org/Team:Shanghai_Metro_Utd">Home</a> | ||
+ | </li> | ||
+ | <li class="active"> | ||
+ | <a href="">Project</a> | ||
+ | <div class="sub-nav"> | ||
+ | <ul> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Description" | ||
+ | class="sub-nav-74">Description</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Experiments" | ||
+ | class="sub-nav-74">Experiments</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Results" | ||
+ | class="sub-nav-74">Results</a></li> | ||
+ | <li class="current-sub-nav"><a href="#" class="sub-nav-52">Proof Of Concept</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Notebook" | ||
+ | class="sub-nav-52">Notebook</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Safety">Safety</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="">Parts</a> | ||
+ | <div class="sub-nav"> | ||
+ | <ul> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Parts" class="sub-nav-74">Parts | ||
+ | Collection</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Engineering" | ||
+ | class="sub-nav-74">Engineering</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Contribution" | ||
+ | class="sub-nav-74">Contribution</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="">Human Practices</a> | ||
+ | <div class="sub-nav"> | ||
+ | <ul> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Human_Practices" | ||
+ | class="sub-nav-74">Integrated Human Practice</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Communication" | ||
+ | class="sub-nav-74">Communication</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Fundraising" | ||
+ | class="sub-nav-74">Fundraising</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Implementation">Implementation</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Entrepreneurship">Entrepreneurship</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Model">Model</a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="">Team</a> | ||
+ | <div class="sub-nav"> | ||
+ | <ul> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Members" class="sub-nav-74">Team | ||
+ | Members</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Attributions" | ||
+ | class="sub-nav-74">Attributions</a></li> | ||
+ | <li><a href="https://2021.igem.org/Team:Shanghai_Metro_Utd/Collaborations" | ||
+ | class="sub-nav-74">Collaborations</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </nav> | ||
+ | <div class="sub-content"> | ||
+ | <div class="sub-title">Proof of Concept</div> | ||
+ | <div class="article-title">Overview</div> | ||
+ | <div class="article-content">Angiogenin has been found to play important roles in various physiological and | ||
+ | pathological processes, especially in neurodegenerative diseases, such as Alzheimer’s Disease (AD), | ||
+ | Parkinson’s disease dementia (PDD), and cerebrovascular disease (CVD). </div> | ||
+ | <div class="article-content">Angiogenin contributes to cell migration, invasion, vessel elongation, and | ||
+ | neuroprotection. Produced by a spectrum of cell categories, such as the vascular endothelial cells and | ||
+ | smooth muscle cells, and it can be recognized by the endothelial cells and elicits second messenger systems. | ||
+ | Angiogenin is also found to be potential in curing neuro-diseases like Parkinson’s Disease and Alzheimer’s | ||
+ | Disease.</div> | ||
+ | <div class="article-content">In addition, the interaction between Angiogenin and Heparin remains to be an | ||
+ | unsolved problem in pharmacological research. </div> | ||
+ | <div class="article-content">Thus, our project aims at 1) acquiring a recombinant E. coli by introducing the | ||
+ | plamid pET-28a-rANG that can secret functional ANG protein, which could possibly serve as an in vitro method | ||
+ | to massive produce ANG for clinical application; 2) initially exploring the relationship between Angiogenin | ||
+ | and Heparin, consolidating a foundation for future pharmacological research. </div> | ||
+ | <div class="article-title">Supporting Experiment Results </div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/6/62/T--Shanghai_Metro_Utd--Proof_of_Concept01.jpg" alt="" /> | ||
+ | <span>Figure 1: The gel electrophoresis map of PCR</span> | ||
+ | </div> | ||
+ | <div class="article-content">Lane 1 to 6 is the result of PCR. We got rANG band at around 400bp (369bp). Enzyme | ||
+ | digestion was conducted and it was linked with digested pET-28a.</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/5/5d/T--Shanghai_Metro_Utd--chg2.jpg" alt="" /> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/3/3e/T--Shanghai_Metro_Utd--chg3.jpg" /> | ||
+ | <span>Figure 2. E. coil having the desired pET28a-rANG</span> | ||
+ | </div> | ||
+ | <div class="article-content"> | ||
+ | The plates in figure 2(1) showed monoclonals of pET28a-rANG constructs.<br /> | ||
+ | The pET28a-rANG was constructed successfully which has been proved by sequencing as shown in figure 2 (2). | ||
+ | </div> | ||
+ | <div class="article-title">Recombination E. coli</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/8/87/T--Shanghai_Metro_Utd--Proof_of_Concept03.jpg" alt="" /> | ||
+ | <span>Figure 3: the scanning gel electrophoresis map of Colony PCR (the top was before and the bottom was | ||
+ | after)</span> | ||
+ | </div> | ||
+ | <div class="article-content">Lane NC to XCN6 and lane XCN7 to N6 are the results of colony PCR. We get the band | ||
+ | 531bp at 500bp around. It indicates that the obtained recombinant monoclonals were positive monoclonals | ||
+ | containing the pET-28a-rANG recombinant plasmid.</div> | ||
+ | <div class="article-title">SDS PAGE</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/d/dd/T--Shanghai_Metro_Utd--Proof_of_Concept04.jpg" alt="" /> | ||
+ | <span>Figure 4. SDS-PAGE Analyzing the proteins before and after induction, within inclusion bodies, and in | ||
+ | supernatants. </span> | ||
+ | </div> | ||
+ | <div class="article-content">The results for SDS-PAGE shows that the induction was successful, and the target | ||
+ | protein (about 15KDa) was mainly in the inclusion body.</div> | ||
+ | <div class="article-title">Protein Purification</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/1/1d/T--Shanghai_Metro_Utd--chg4.jpg" alt="" /> | ||
+ | <span>Figure 5. SDS-PAGE and stained with Coomassie Brilliant Blue after protein purifying: (1) first | ||
+ | attempt; (2) second attempt</span> | ||
+ | </div> | ||
+ | <div class="article-content">Based on figure 5 (1), there was a band at 15 KDa before passing through the column | ||
+ | but disappeared after passing through the column, indicating that the protein had hung the column. But we | ||
+ | notice that there is a miscellaneous band with a small amount. In order to obtain the purified protein, we | ||
+ | repeated the protein purification experiments and finally obtained the more purified protein as seen in | ||
+ | figure 5 (2) where you could only see one band at 15 KDa.</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/3/3b/T--Shanghai_Metro_Utd--Proof_of_Concept06.jpg" alt="" /> | ||
+ | <span>Figure 6. First SDS-PAGE, Coomassie blue staining. Samples from left to right: marker; 1.before | ||
+ | column(unconcentrated); 2. after column 1(unconcentrated); 3. after column 2(unconcentrated); 4. | ||
+ | buffer A rinsed; 5 second elution; 6 third elution.</span> | ||
+ | </div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/f/f0/T--Shanghai_Metro_Utd--Proof_of_Concept07.jpg" alt="" /> | ||
+ | <span>Figure 7. Second SDS-PAGE, Coomassie blue staining. Samples from left to right: marker; 1. second | ||
+ | elution; 2.third elution; 3.fourth elution; 4. fifth elution.</span> | ||
+ | </div> | ||
+ | <div class="article-content">It can be seen from Figure 6 and Figure 7 that there is actually not much | ||
+ | protein after the third elution.</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/4/4e/T--Shanghai_Metro_Utd--Proof_of_Concept08.jpg" alt="" /> | ||
+ | <span>Figure 8 Lyophilized protein</span> | ||
+ | </div> | ||
+ | <div class="article-content">As seen in figure 8, the protein was successfully lyophilized into the form of | ||
+ | powder.</div> | ||
+ | <div class="article-title">RNA Extraction</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/c/cf/T--Shanghai_Metro_Utd--Proof_of_Concept09.jpg" alt="" /> | ||
+ | <span>Figure 9. The concentration of the extracted RNA by nanodrop</span> | ||
+ | </div> | ||
+ | <div class="article-title">RNA Degradation Experiment</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/5/5a/T--Shanghai_Metro_Utd--Proof_of_Concept10.jpg" alt="" /> | ||
+ | <span>Figure 10. electrophoresis map after RNA degradation tests </span> | ||
+ | </div> | ||
+ | <div class="article-content">According to the electrophoresis map, the renatured rANG has ribonuclease | ||
+ | activity with the capability | ||
+ | of RNA incomplete degradation and produced a band at about 100 bp, which is consistent with the data in | ||
+ | the literatures (Ref. 1, 2).</div> | ||
+ | <div class="img-wrap no-margin"> | ||
+ | <img src="https://static.igem.org/mediawiki/2021/c/cb/T--Shanghai_Metro_Utd--Proof_of_Concept11.jpg" alt="" /> | ||
+ | <span>Figure 11. OD<sub>450</sub> curve of the system with heparin and rANG</span> | ||
+ | </div> | ||
+ | <div class="article-content">The OD<sub>450</sub> could indicate the interaction ability between heparin and | ||
+ | angiogenin which means that the higher the OD<sub>450</sub> value, the greater the interaction ability | ||
+ | between | ||
+ | heparin and angiogenin. This curve shows the more angiogenin we added, the higher the OD<sub>450</sub> | ||
+ | value, | ||
+ | namely the interaction ability between heparin and angiogenin. Therefore, it can be concluded that | ||
+ | the interaction of heparin has dose-dependent with angiogenin.</div> | ||
+ | <div class="article-title">Conclusion</div> | ||
+ | <div class="article-content">According to the experiment results listed above, we successfully obtained a | ||
+ | recombinant | ||
+ | E. coli by introducing the plamid pET-28a-rANG that can secret functional ANG protein. Meanwhile, we | ||
+ | also investigated an initial interaction between angiogenin and heparin. | ||
+ | </div> | ||
+ | <div class="article-content"> | ||
+ | [1]孙德森,盛静浩.重组人血管生成素制备和生物活性鉴定[J].中国生物化学与分子生物学报,2015,31(12):1315-1321. | ||
+ | </div> | ||
+ | <div class="article-content">[2] Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity | ||
+ | of human angiogenin. | ||
+ | Biochemistry. 1986 Jun 17;25(12):3527-32. doi: 10.1021/bi00360a008. Erratum in: Biochemistry 1986 Oct | ||
+ | 21;25(21):6730. PMID: 2424496.</div> | ||
− | <div class=" | + | </div> |
− | + | <footer class="footer"> | |
− | + | <section class="footer-wrap"> | |
− | < | + | <p class="margin-bottom-14">Email us at:<i |
− | < | + | style="color:#0546ff; font-style: normal;">ashleyyang48@gmail.com;alexlin711@gmail.com</i> |
− | < | + | </p> |
− | <p> | + | <p>Follow us on Wechat: <i style="color:#650000; font-size: 18px;">血管马力Bloody |
− | + | Marry</i></p> | |
− | < | + | </section> |
− | + | </footer> | |
− | </ | + | </body> |
− | + | <script> | |
+ | let liTags = document.querySelectorAll(".top-nav-bar > ul > li"); | ||
+ | let len = liTags.length; | ||
+ | for (let i = 0; i < len; i++) { | ||
+ | liTags[i].onclick = function (e) { | ||
+ | //先移除所有的点击样式 | ||
+ | for (let j = 0; j < len; j++) { | ||
+ | liTags[j].classList.remove("active"); | ||
+ | } | ||
+ | //再添加点击样式 | ||
+ | let li = e.currentTarget; | ||
+ | li.classList.add("active"); | ||
+ | } | ||
+ | } | ||
+ | </script> | ||
</html> | </html> |
Latest revision as of 19:01, 19 October 2021
Proof of Concept
Overview
Angiogenin has been found to play important roles in various physiological and
pathological processes, especially in neurodegenerative diseases, such as Alzheimer’s Disease (AD),
Parkinson’s disease dementia (PDD), and cerebrovascular disease (CVD).
Angiogenin contributes to cell migration, invasion, vessel elongation, and
neuroprotection. Produced by a spectrum of cell categories, such as the vascular endothelial cells and
smooth muscle cells, and it can be recognized by the endothelial cells and elicits second messenger systems.
Angiogenin is also found to be potential in curing neuro-diseases like Parkinson’s Disease and Alzheimer’s
Disease.
In addition, the interaction between Angiogenin and Heparin remains to be an
unsolved problem in pharmacological research.
Thus, our project aims at 1) acquiring a recombinant E. coli by introducing the
plamid pET-28a-rANG that can secret functional ANG protein, which could possibly serve as an in vitro method
to massive produce ANG for clinical application; 2) initially exploring the relationship between Angiogenin
and Heparin, consolidating a foundation for future pharmacological research.
Supporting Experiment Results
![](https://static.igem.org/mediawiki/2021/6/62/T--Shanghai_Metro_Utd--Proof_of_Concept01.jpg)
Lane 1 to 6 is the result of PCR. We got rANG band at around 400bp (369bp). Enzyme
digestion was conducted and it was linked with digested pET-28a.
![](https://static.igem.org/mediawiki/2021/5/5d/T--Shanghai_Metro_Utd--chg2.jpg)
![](https://static.igem.org/mediawiki/2021/3/3e/T--Shanghai_Metro_Utd--chg3.jpg)
The plates in figure 2(1) showed monoclonals of pET28a-rANG constructs.
The pET28a-rANG was constructed successfully which has been proved by sequencing as shown in figure 2 (2).
The pET28a-rANG was constructed successfully which has been proved by sequencing as shown in figure 2 (2).
Recombination E. coli
![](https://static.igem.org/mediawiki/2021/8/87/T--Shanghai_Metro_Utd--Proof_of_Concept03.jpg)
Lane NC to XCN6 and lane XCN7 to N6 are the results of colony PCR. We get the band
531bp at 500bp around. It indicates that the obtained recombinant monoclonals were positive monoclonals
containing the pET-28a-rANG recombinant plasmid.
SDS PAGE
![](https://static.igem.org/mediawiki/2021/d/dd/T--Shanghai_Metro_Utd--Proof_of_Concept04.jpg)
The results for SDS-PAGE shows that the induction was successful, and the target
protein (about 15KDa) was mainly in the inclusion body.
Protein Purification
![](https://static.igem.org/mediawiki/2021/1/1d/T--Shanghai_Metro_Utd--chg4.jpg)
Based on figure 5 (1), there was a band at 15 KDa before passing through the column
but disappeared after passing through the column, indicating that the protein had hung the column. But we
notice that there is a miscellaneous band with a small amount. In order to obtain the purified protein, we
repeated the protein purification experiments and finally obtained the more purified protein as seen in
figure 5 (2) where you could only see one band at 15 KDa.
![](https://static.igem.org/mediawiki/2021/3/3b/T--Shanghai_Metro_Utd--Proof_of_Concept06.jpg)
![](https://static.igem.org/mediawiki/2021/f/f0/T--Shanghai_Metro_Utd--Proof_of_Concept07.jpg)
It can be seen from Figure 6 and Figure 7 that there is actually not much
protein after the third elution.
![](https://static.igem.org/mediawiki/2021/4/4e/T--Shanghai_Metro_Utd--Proof_of_Concept08.jpg)
As seen in figure 8, the protein was successfully lyophilized into the form of
powder.
RNA Extraction
![](https://static.igem.org/mediawiki/2021/c/cf/T--Shanghai_Metro_Utd--Proof_of_Concept09.jpg)
RNA Degradation Experiment
![](https://static.igem.org/mediawiki/2021/5/5a/T--Shanghai_Metro_Utd--Proof_of_Concept10.jpg)
According to the electrophoresis map, the renatured rANG has ribonuclease
activity with the capability
of RNA incomplete degradation and produced a band at about 100 bp, which is consistent with the data in
the literatures (Ref. 1, 2).
![](https://static.igem.org/mediawiki/2021/c/cb/T--Shanghai_Metro_Utd--Proof_of_Concept11.jpg)
The OD450 could indicate the interaction ability between heparin and
angiogenin which means that the higher the OD450 value, the greater the interaction ability
between
heparin and angiogenin. This curve shows the more angiogenin we added, the higher the OD450
value,
namely the interaction ability between heparin and angiogenin. Therefore, it can be concluded that
the interaction of heparin has dose-dependent with angiogenin.
Conclusion
According to the experiment results listed above, we successfully obtained a
recombinant
E. coli by introducing the plamid pET-28a-rANG that can secret functional ANG protein. Meanwhile, we
also investigated an initial interaction between angiogenin and heparin.
[1]孙德森,盛静浩.重组人血管生成素制备和生物活性鉴定[J].中国生物化学与分子生物学报,2015,31(12):1315-1321.
[2] Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity
of human angiogenin.
Biochemistry. 1986 Jun 17;25(12):3527-32. doi: 10.1021/bi00360a008. Erratum in: Biochemistry 1986 Oct
21;25(21):6730. PMID: 2424496.